Advertisement

Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




Mar
09
Today In Oncology
Partial Gland Removal May Be an Option for Many Men With Prostate Cancer
How the Cancer Moonshot Is Making a Difference for Patients Here and Across the World
Greater Plant Based Oil Lower Butter Intake Could Improve Risk of Cancer Related Mortality
Breast Cancer Mortality Rates May Have Stopped Declining
SGLT2 Inhibitors Could Help Protect Against Heart Failure in Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo